Current innovations in cancer organoid modelling for drug discovery

Over 95% of potential anti-cancer drugs failed in clinical trials despite vast investment to bring the drug to market. The last decade of cancer research has also seen numerous advances aimed at improving the efficacy of treatments and decreasing attrition rates of drug candidates. In this crucial webinar, we explore the latest developments in cancer organoid (tumoroid) technology and its promising implications for drug screening. Discover how to establish next-gen tumoroid models from patient derived tumor cells using a novel culture system (OncoPro medium) and high content analysis platform. Gain insights to areas of optimization and learn to leverage these advanced organoid models for large-scale studies and functional assay development. Finally, hear from industry experts as they share cutting-edge innovations and expertise in functional precision medicine to shape the future of cancer research and care.

 

Learning Objectives: